Overview
High-Purity Healthy CD56+ NK Cells for Immunology and Oncology Research
Healthy CD56+ NK Cells are freshly isolated or cryopreserved from peripheral blood of rigorously screened, IRB-consented healthy donors. These natural killer (NK) cells are CD3-negative, CD56-positive lymphocytes essential to the innate immune response. Ideal for studies involving immune surveillance, cancer immunotherapy, cytotoxicity, and viral response mechanisms.
Product Features
- Research Use Only (RUO), CD56+ enriched NK cells
- Isolated from healthy adult donors
- High viability and purity (>90% CD56+ NK cells)
- Available fresh or cryopreserved in CryoStore® CS10 media
- Processed within 24 hours of collection
- IRB-approved, ethically sourced, and HIPAA-compliant
Donor Metadata
- Comprehensive donor screening: health history, demographics
- Age, sex assigned at birth, race/ethnicity available
- Self-reported allergies and medication use
Applications
- Cancer immunotherapy development and screening
- Cytotoxicity and killing assays
- Single-cell and transcriptomic analysis of NK cells
- Studies on NK-mediated immune modulation
Compliance and Quality Assurance
- Collected with IRB-approved protocols and 21 CFR Part 11–compliant e-consent
- Rigorous donor screening and documentation
- HIPAA-compliant data handling
Ordering & Customization
Healthy CD56+ NK Cells are available in standard or custom aliquots for both fresh and frozen formats. For international orders or regulatory compliance documentation, please contact .
Protocol and Documentation
Document Type | Technical Document | Catalog | Language |
---|---|---|---|
PDF > | Immune Cell Isolation | - | - |
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
- Total nucleated cell (TNC) count
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.